Compare Mutual Funds

Pros

-

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
-
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

4 Years 10 Months

13 Years 10 Months

Fund AUM

₹263 Cr

₹9279 Cr

Min Investment
  1. SIP ₹500
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

0.98%

1%

Exit Load

0.5%

1%

Benchmark Index

Nifty Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

39

38

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(13.26%)
  2. Divi's Laboratories Ltd(7.97%)
  3. Apollo Hospitals Enterprise Ltd(6.05%)
  4. Max Healthcare Institute Ltd Ordinary Shares(5.05%)
  5. Torrent Pharmaceuticals Ltd(4.84%)
  1. Sun Pharmaceuticals Industries Ltd(13.31%)
  2. Lupin Ltd(7.25%)
  3. Divi's Laboratories Ltd(6.52%)
  4. Cipla Ltd(6.03%)
  5. Apollo Hospitals Enterprise Ltd(5.3%)
No of Sectors

4

1

Top 3 Sectors
  1. Health(95.96%)
  2. Basic Materials(3.09%)
  3. Industrial(0.48%)

Health

(100%)

Equity %

97.88%

97.32%

Debt %

-

-

P/E

43.65

39.56

P/B

6.03

5.84

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

0.31%

-0.13%

3-Month Return

10.23%

7.73%

6-Month Return

17.83%

13.29%

1-Year Return

13.12%

11.67%

3-Year Return

20.53%

19.37%

5-Year Return

-

13.55%

Sharpe

0.88

0.89

Alpha

0.06

-1.21

Beta

0.95

0.88

Standard Deviation

16.42

14.77

Information Ratio

-0.16

-0.88

Description

ITI Pharma and Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Animesh Singh, Nilay Dalal

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons